The North America monoclonal antibodies market is expected to reach US$ 1,20,713.2 million by 2028 from US$ 54,629.4 million in 2021. The market is estimated to grow at a CAGR of 12.0% from 2021–2028.
Biosimilars, which are highly similar versions of existing monoclonal antibodies, are gaining regulatory and clinical acceptance, offering cost-effective alternatives that can broaden...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek